Innate Pharma

IPHA

NYSE EURONEXT - EURONEXT PARISHealth Care

Income Statement

Total Revenue$226.43M

Gross Profit$226.43M

Operating Income$-95.95M

EBITDA$-47.46M

EBIT$-66.51M

Pre-tax Income$-119.99M

Net Income$-76.77M

Cash Equivalent$74.53M

Total Debt$38.24M

Book Value$45.25M

Book Value Per Share0.56

Return on Equity (ROE)-560.01%

Return on Assets (ROA)-44.54%

Return on Invested Capital (ROI)-55.96%

Net Profit Margin-391.94%

Current Ratio2.60

Quick Ratio2.60

Long-Term Debt / Equity7.18